These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 8391923

  • 1. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
    Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Ozer HL, Schwab M, Albino AP, Old LJ.
    Cancer Res; 1993 Jul 15; 53(14):3327-35. PubMed ID: 8391923
    [Abstract] [Full Text] [Related]

  • 2. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.
    Cheng JD, Dunbrack RL, Valianou M, Rogatko A, Alpaugh RK, Weiner LM.
    Cancer Res; 2002 Aug 15; 62(16):4767-72. PubMed ID: 12183436
    [Abstract] [Full Text] [Related]

  • 3. Fibroblast activation protein: purification, epitope mapping and induction by growth factors.
    Rettig WJ, Su SL, Fortunato SR, Scanlan MJ, Raj BK, Garin-Chesa P, Healey JH, Old LJ.
    Int J Cancer; 1994 Aug 01; 58(3):385-92. PubMed ID: 7519584
    [Abstract] [Full Text] [Related]

  • 4. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor.
    Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P, Houghton AN.
    Oncogene; 2004 Jul 15; 23(32):5435-46. PubMed ID: 15133496
    [Abstract] [Full Text] [Related]

  • 5. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
    Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old LJ, Rettig WJ.
    Proc Natl Acad Sci U S A; 1994 Jun 07; 91(12):5657-61. PubMed ID: 7911242
    [Abstract] [Full Text] [Related]

  • 6. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, Kang D, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S, Fisher PB.
    Oncogene; 2001 Oct 25; 20(48):7051-63. PubMed ID: 11704829
    [Abstract] [Full Text] [Related]

  • 7. Cytochemical and molecular properties of simian virus 40 transformed Kaposi's sarcoma-derived cells: evidence for the secretion of a member of the fibroblast growth factor family.
    Werner S, Hofschneider PH, Stürzl M, Dick I, Roth WK.
    J Cell Physiol; 1989 Dec 25; 141(3):490-502. PubMed ID: 2556409
    [Abstract] [Full Text] [Related]

  • 8. Expression of the fibroblast activation protein during mouse embryo development.
    Niedermeyer J, Garin-Chesa P, Kriz M, Hilberg F, Mueller E, Bamberger U, Rettig WJ, Schnapp A.
    Int J Dev Biol; 2001 Apr 25; 45(2):445-7. PubMed ID: 11330865
    [Abstract] [Full Text] [Related]

  • 9. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, Chen WT, Cheng JD.
    Clin Cancer Res; 2007 Mar 15; 13(6):1736-41. PubMed ID: 17363526
    [Abstract] [Full Text] [Related]

  • 10. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
    Lee J, Fassnacht M, Nair S, Boczkowski D, Gilboa E.
    Cancer Res; 2005 Dec 01; 65(23):11156-63. PubMed ID: 16322266
    [Abstract] [Full Text] [Related]

  • 11. Expression of stromal cell markers in distinct compartments of human skin cancers.
    Huber MA, Kraut N, Schweifer N, Dolznig H, Peter RU, Schubert RD, Scharffetter-Kochanek K, Pehamberger H, Garin-Chesa P.
    J Cutan Pathol; 2006 Feb 01; 33(2):145-55. PubMed ID: 16420310
    [Abstract] [Full Text] [Related]

  • 12. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis.
    Levy MT, McCaughan GW, Abbott CA, Park JE, Cunningham AM, Müller E, Rettig WJ, Gorrell MD.
    Hepatology; 1999 Jun 01; 29(6):1768-78. PubMed ID: 10347120
    [Abstract] [Full Text] [Related]

  • 13. Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors.
    Palman C, Bowen-Pope DF, Brooks JJ.
    Lab Invest; 1992 Jan 01; 66(1):108-15. PubMed ID: 1309926
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line.
    Wang XM, Yu DM, McCaughan GW, Gorrell MD.
    Hepatology; 2005 Oct 01; 42(4):935-45. PubMed ID: 16175601
    [Abstract] [Full Text] [Related]

  • 15. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
    Fassnacht M, Lee J, Milazzo C, Boczkowski D, Su Z, Nair S, Gilboa E.
    Clin Cancer Res; 2005 Aug 01; 11(15):5566-71. PubMed ID: 16061874
    [Abstract] [Full Text] [Related]

  • 16. Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
    Ge Y, Zhan F, Barlogie B, Epstein J, Shaughnessy J, Yaccoby S.
    Br J Haematol; 2006 Apr 01; 133(1):83-92. PubMed ID: 16512833
    [Abstract] [Full Text] [Related]

  • 17. Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin.
    Dolznig H, Schweifer N, Puri C, Kraut N, Rettig WJ, Kerjaschki D, Garin-Chesa P.
    Cancer Immun; 2005 Aug 03; 5():10. PubMed ID: 16076089
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT, Singal PK, Al-Banaw A.
    Anticancer Res; 2007 Aug 03; 27(6B):4201-18. PubMed ID: 18225592
    [Abstract] [Full Text] [Related]

  • 19. NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer.
    Christianson TA, Doherty JK, Lin YJ, Ramsey EE, Holmes R, Keenan EJ, Clinton GM.
    Cancer Res; 1998 Nov 15; 58(22):5123-9. PubMed ID: 9823322
    [Abstract] [Full Text] [Related]

  • 20. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
    Welt S, Divgi CR, Scott AM, Garin-Chesa P, Finn RD, Graham M, Carswell EA, Cohen A, Larson SM, Old LJ.
    J Clin Oncol; 1994 Jun 15; 12(6):1193-203. PubMed ID: 8201382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.